Drug Manufacturers
- 1244.799
- +0.425+0.03%
BRIEF-Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
Nov 24 (Reuters) - Seelos Therapeutics Inc SEEL.O :* SEELOS THERAPEUTICS ANNOUNCES ACQUISITION OF AN EXCLUSIVE LICENSE OF IX BIOPHARMA'S PROPRIETARY WAFER-BASED DELIVERY PLATFORM FOR SUBLINGUAL KETAM
IX Biopharma Says Entered Exclusive License Agreement With Seelos Therapeutics; iX Biopharma to Receive a $9M Upfront Plus Up to $239M in Milestone Payments Plus Royalties
iX Biopharma Ltd (SGX:42C), a specialty pharmaceutical company that develops innovative therapies using its proprietary sublingual drug delivery technology, WaferiX, announced today that it has, throu
Singapore Shares Close Marginally Lower; Nutryfarm Climbs 3% on Securing Order for 100 Containers of Durians
04:32 AM EST, 11/24/2021 (MT Newswires) -- Singapore's Straits Times Index opened higher on Wednesday before marginally closing in the red, despite the positive news that the city-state's gross domes
BRIEF-IX Biopharma Says Entered Exclusive License Agreement With Seelos Therapeutics
Nov 24 (Reuters) - IX Biopharma Ltd IXBI.SI :* ENTERED INTO AN EXCLUSIVE LICENSE AGREEMENT WITH SEELOS THERAPEUTICS* WILL RECEIVE US$9 MILLION UPFRONT PAYMENT TO BE SATISFIED IN CASH AND SHARES* ALSO
3 Stocks You Can Buy for Your Child’s Investment Account
It's always good to start investing as early as possible. Here are three stocks you can consider buying for your child's investment account. The post 3 Stocks You Can Buy for Your Child’s Investment Account appeared first on The Smart Investor.
IX Biopharma Signs Wafesil Licensing, Distribution Deal with China Resources Pharmaceutical Unit
03:48 AM EDT, 09/30/2021 (MT Newswires) -- IX Biopharma (SGX:42C) and a unit of China Resources Pharmaceutical (HKG:3320) signed a 10-year deal for the licensing, supply and distribution of Wafesil i
IX Biopharma Trims FY21 Loss Amid Robust Product Demand in China
12:34 AM EDT, 08/24/2021 (MT Newswires) -- IX Biopharma (SGX:42C) slashed its net loss by 22% in the full fiscal year ended June 30 thanks to the 77% surge in revenue from its expansion in China. Lo
iX Biopharma gets green light to export medicinal cannabis wafers
Specialty pharmaceutical company iX Biopharma has obtained export listing status for Xativa, its CBD (cannabidiol) sublingual wafer. In a press release on June 28, iX Biopharma announced Xativa's inclusion in the Australian Register of Therapeutic Goods' (ARTG) list of drugs approved for export.
SG Morning Highlights: CapitaLand to divest partial stakes in six China projects
Stocks to watch: CapitaLand, iX Biopharma, Japfa, Sarine Tech, Ascott Residence Trust, OUELH, Keppel, SIA.
iX Biopharma to expand wafer production capacity at Australian facility
Specialty pharmaceutical company iX Biopharma has announced that it will expand its current wafer production capacity at its manufacturing facility in Australia.
SG Morning Highlights: Stocks fall at Wednesday's open; STI down 0.3%
Stocks to watch: Keppel Infra Trust, Boustead Projects, iX Biopharma, Raffles Medical, Wee Hur.
SG Morning Bell: Stocks open higher on Wednesday
Stocks to watch: ST Engg, Trendlines, iX Biopharma, 3Cnergy, Yinda Infocomm
SG Morning Bell: Stocks open higher on Monday; STI up 0.3%
Stocks to watch: a-iTrust, Sembmarine, Tianjin Zhong Xin, DBS, iFast, Nanofilm
Jinhushen Bio completes 67% acquisition with Tianjin Pharma, S shares offer price revised
Stocks That Hit 52-Week Highs On Thursday
This morning 77 companies reached new 52-week highs. Noteworthy Mentions: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a new 52-week high.AirNet Technology (NASDAQ:ANTE)